Abstract
Background
It is unknown whether certain factors are associated with the success of in vitro fertilization (IVF) in women with inflammatory bowel disease (IBD).
Aim
This study assessed whether certain characteristics are associated with greater success of live birth following IVF.
Methods
In a cohort study of 8684 women with IBD seen at two tertiary care centers, we identified 121 women with IBD who underwent IVF. We assessed the effect of numerous factors on likelihood of achieving live birth after IVF.
Results
Seventy-one patients with ulcerative colitis (UC) and 49 patients with Crohn’s disease (CD) were analyzed. Patients with UC who achieved a live birth were younger (p = 0.03), had a shorter duration of disease (p = 0.01), and were more likely to be in remission (p = 0.03) versus those who did not achieve live birth. Patients with CD who achieved live birth were younger (p < 0.001), had lower body mass index (BMI) (p = 0.02), and had lower cycle day 3 follicle-stimulating hormone levels (p = 0.02). There was no difference in likelihood of achieving live birth among patients in remission and those with mild or unknown disease status (p = 0.69), though most CD patients (79.5 %) were in remission. Prior surgery was not associated with live birth in patients with UC (p = 0.31) or CD (p = 0.62).
Conclusions
As in the general infertility population, younger patients and those with lower BMI were more likely to achieve live birth. History of surgery was not associated with live birth among IBD patients. This is important information for practitioners counseling IBD patients.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- CD:
-
Crohn’s disease
- IVF:
-
In vitro fertilization
- IBD:
-
Inflammatory bowel disease
- IQR:
-
Interquartile range
- UC:
-
Ulcerative colitis
- CD3 FSH:
-
Cycle day three follicle-stimulating hormone
- BIDMC:
-
Beth Israel Deaconess Medical Center
- BWH:
-
Brigham and Women’s Hospital
- HBI:
-
Harvey–Bradshaw Index
- IPAA:
-
Ileal pouch anal anastomosis
References
Narri SR, Ahn C, Buchman A. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:591–599.
Manosa M, Navarro-Llavat M, Marin L, et al. Fecundity, pregnancy outcomes and breastfeeding in patients with inflammatory bowel disease: a large cohort study. Scand J Gastroenterol. 2013;48:427–432.
Muller KR, Prosser R, Bampton P, et al. Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions. Inflamm Bowel Dis. 2010;16:657–663.
Marin L, Manosa M, Garcia-Planella E, et al. Sexual function and patients’ perceptions in inflammatory bowel disease: a case–control survey. J Gastroenterol. 2012;48:713–720.
Wikland M, Jansson I, Asztely M, et al. Gynaecological problems related to anatomical changes after conventional proctocolectomy and ileostomy. Int J Colorectal Dis. 1990;5:49–52.
Oresland T, Palmblad S, Ellstrom M, et al. Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy. Int J Colorectal Dis. 1994;9:77–81.
Cornish JA, Tan E, Teare J, et al. The effect of restorative proctocolectomy on sexual function, urinary function, pregnancy and delivery: a systematic review. Dis Colon Rectum. 2007;50:1128–1138.
Waljee A, Waljee J, Morr AM, et al. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006;55:1575–1580.
Oza SS, Pabby V, Dodge LE, et al. In vitro fertilization in women with inflammatory bowel disease is as successful as in women from the general infertility population. Clin Gastroenterol Hepatol. 2015;13:1641–1646.
Pabby V, Oza SS, Dodge LE, et al. In vitro fertilization is successful in women with ulcerative colitis and ileal pouch anal anastomosis. Am J Gastroenterol. 2015;110:792–797.
Abhyankar A, Ham M, Moss AC. Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38:460–466.
Author contributions
Sveta Shah Oza, MD, contributed to the study concept and design, acquisition of data, analysis and interpretation of data, and drafting of the manuscript; Vikas Pabby, MD, contributed to study concept and design, acquisition of data, and analysis and interpretation of data; Laura E. Dodge, MPH, and Michele R. Hacker, ScD, analyzed and interpreted the data and drafted the manuscript; Janis H. Fox, MD, designed the study and analyzed and interpreted the data; Vasiliki A. Moragianni, MD, MS, was involved in study design, acquisition of data, and analysis and interpretation of data; Katharine Correia, MPH, and Stacey A. Missmer, ScD, contributed to study design and analysis and interpretation of data; Yetunde Ibrahim, MD, was involved in acquisition of data; Alan Penzias, MD, and Robert Burakoff, MD, contributed to study concept and design and analysis and interpretation of data; Sonia Friedman, MD, and Adam S. Cheifetz, MD, was involved in study concept and design, acquisition of data, analysis and interpretation of data, and drafting of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Adam S. Cheifetz: Consulting/research: Janssen, Abbvie, Takeda, Pfizer, UCB, Prometheus; Alan Penzias: Advisory Board (with compensation): OvaScience; Nora Therapeutics; Consultant: ReproSource, Inc; Speakers Bureau: Ferring Pharmaceuticals; Michele R. Hacker: Support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers; Sveta Shah Oza, Vikas Pabby, Laura E. Dodge, Vasiliki A. Moragianni, Janis H. Fox, Katherine Correia, Stacey A. Missmer, Yetunde Ibrahim, Robert Burakoff, and Sonia Friedman have no disclosures or conflicts of interests.
Additional information
Sonia Friedman and Adam S. Cheifetz: Shared senior authorship also contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Oza, S.S., Pabby, V., Dodge, L.E. et al. Factors Associated with the Success of In Vitro Fertilization in Women with Inflammatory Bowel Disease. Dig Dis Sci 61, 2381–2388 (2016). https://doi.org/10.1007/s10620-016-4076-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-016-4076-7